N ormal epithelial cells depend on stroma, consisting of extracellular matrix and mesenchymal and nerve cells, to sustain their survival and proliferation. Alterations in the stroma are central to carcinogenesis (1) . Most of these cell lineages in the stroma have been identified as "coconspirators" either hindering the elimination (2) or helping the formation and development (3) of cancer.
The development of an epithelial malignancy is a multistep process in which a preinvasive lesion gradually acquires the capacity to invade (4) . However, the stage at which the stromal compartment contributes to the de novo development of cancer is unknown. Precursor lesions exist for most gastrointestinal tumors. Esophageal adenocarcinoma (EAC) develops through a premalignant, metaplastic lesion called Barrett's esophagus (BE). BE is an ideal tool for the study of cancer progression because it is visible endoscopically and highly accessible, there is a field effect that can be spatially mapped, and patients are monitored over time, giving rise to longitudinal data (5) . Furthermore, gastroesophageal reflux is the key risk factor for this rapidly increasing disease (6, 7) ; BE could therefore be regarded as a response to chronic injury, and in this context the stroma might be predicted to play an important role.
We hypothesized that the altered expression of stromal genes influences the progression from preinvasive to invasive disease.
An unbiased expression-array analysis in microdissected stroma from different stages of EAC progression was performed, and stromal genes affecting prognosis were identified. Expression of genes of interest was validated on independent human samples to establish the cellular source of expression and their functional relevance. The significance of our esophageal stromal signature was assessed in other gastrointestinal cancers with a wellcharacterized preinvasive stage.
Results

Distinct Stromal Signatures Separate Different Stages of BE
Progression. The stroma from metaplasia, dysplasia, and EAC was microdissected, and gene expression was analyzed using an Agilent 44k array. Pair-wise comparison of gene expression in the stroma alone was sufficient to differentiate between the stages of progression ( Fig. 1 ; P < 10 −4 in each case).
Identification of Key Genes. The most consistently dysregulated genes from the metaplasia-dysplasia-EAC sequence were identified using strict filtering and short-listing criteria (SI Materials and Methods and Fig. S1 ). The 12 short-listed genes encompass a number of functions: inflammatory mediators [interleukin 6 (IL-6), cyclooxygenase 2 (Cox-2), and CCAAT element binding protein beta (C/EBPβ)]; TGF-β-related genes [thrombospondin 1 (TSP1), periostin (POSTN), and transmembrane prostate androgen induced (TMEPAI)]; potential modulators of invasion [matrix metalloproteinase 1 (MMP1) and junction-mediating and regulatory protein (JMY) (8) ]; transcription factors [B cell lymphoma-6 (BCL6)]; metabolizing enzyme for toxicants and carcinogens [UDP glucuronosyltransferase 1 family, polypeptide A4 (UGT1A4)]; and unsurprisingly, stromal activation markers [fibroblast activation protein alpha (Fap-α) and alpha smooth muscle actin (α-SMA)].
Their stromal expression was confirmed at the protein level by immunohistochemistry (IHC) for all up-regulated targets for which specific antibodies were available, to enable cell localization to be determined. The predominant stromal cell lineages expressing the targets of interest were fibroblasts, inflammatory cells, and endothelial cells (Fig. S2 ). Specific antibodies were not available for C/EBPβ, JMY, and IL-6. However, IL-6 is known to be expressed by fibroblasts and inflammatory cells (9) . C/EBPβ is central to IL-17 stimulation of MMP1 in fibroblasts (11) and was shown to stimulate COX-2 and IL-8 expression (10), implying a stromal localization. UGT1A4 was the only significantly downregulated target short-listed ( Fig. S1 ), and because no antibody was available this was validated by in situ hybridization, which showed both epithelial and stromal localization ( Fig. S2 ).
Expression of Stromal Genes Predicts Poor Outcome in EAC.
Functional relevance of this stromal signature was determined by linking the expression level of the 12 targets to outcome for 63 chemo-naïve patients with invasive EAC. Up-regulation of TMEPAI and JMY was significantly associated with a worse prognosis (P < 0.005 for both; Fig. S3 ), and up-regulation of TSP1, FAPα, and BCL6 had a trend for significantly worse outcome. Patients with up-regulation of any one or more of these five targets had a worse prognosis than patients with no increase in expression of any of these stromal genes (P = 0.022; Fig. 2 ).
Inflammation Ontologies Are Up-Regulated in the Progression from Metaplasia to EAC. Key processes altered along the disease sequence were determined by ontology analysis by comparing metaplasia vs. dysplasia and dysplasia vs. EAC. Ontologies conserved along the metaplasia-dysplasia-EAC sequence contained up-regulation of inflammation-related genes (three ontologies: mediation of immune response, inflammatory response, and negative regulation of immune response) and cellcell communication related genes (two ontologies: cell-cell signaling and cell surface receptor linked signal transduction) (Table 1 ). Furthermore, analysis of signaling pathways deposited in a public database [Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways] highlighted the statistically significant up-regulation of cytokine-cytokine receptor interaction in the metaplasia vs. dysplasia comparison and of the TGF-β pathway in the dysplasia vs. EAC comparison ( Table 1 ). These data are particularly striking because, in keeping with the supervised clustering analyses, the most dysregulated genes are inflammation-related genes (IL-6, C/EBPβ, and Cox-2) and are TGF-β-related genes (TMEPAI, POSTN, and TSP1) ( Fig. S1 ).
Fibroblasts Express Similar Inflammation-Related Ontologies.
Because seven of eight (with suitable antibodies) of the most dysregulated stromal genes were expressed by fibroblasts (TMEPAI, BCL6, MMP1, TSP1, POSTN, αSMA, and FAPα), we expression profiled 13 clonally derived primary stromal fibroblasts (origin confirmed; Fig. S4 ), generated from metaplasia, dysplasia, and EAC specimens (SI Materials and Methods). Three of 12 key genes, MMP1, IL-6, and COX-2, were dysregulated in the fibroblast signature. In addition, the inflammation-related ontologies and KEGG pathways identified for the microdissected stromal biopsy signature were all statistically up-regulated in the fibroblast signature (Table 1 ). Furthermore, three ontologies related to an invasive phenotype (chemotaxis, cell adhesion, and regulation of angiogenesis) differentiated cancerassociated fibroblasts from BE fibroblasts.
Functional Role of Selected Stromal Genes. BCL6, TSP1, and POSTN were selected for further study to investigate their role in progression to cancer because they were validated at the protein level across the metaplasia-dysplasia-EAC sequence ( Fig. S2 ) and had relevance to inflammation and TFG-β and a littleknown role in BE.
In keeping with previous studies (12) (13) (14) , the up-regulated IL-6 levels were positively correlated with transcript levels for BCL6 (P < 0.05) and inversely correlated with TP53 (P = 0.01) and PDCD4 (P < 0.0001) ( Fig. S5 ). In vitro stimulation of the esophageal epithelial cancer cell line FLO-1 with recombinant IL-6 led to a significant and time-dependent increase in BCL6 mRNA expression (10 h vs. 4 and 0 h; P < 0.01), with a con- comitant reduction in TP53 mRNA (10 h vs. 8, 4, and 0 h; P < 0.001) but not of PDCD4 ( Fig. 3A ).
There was a striking increase in the intensity and density of staining for TSP1 in the metaplasia-dysplasia-EAC sequence (P < 0.001 for both; Fig. S2C ). We therefore analyzed the expression of TSP1 in an independent case-control cohort of patients with BE who progressed from metaplasia to cancer over a mean of 6.5 years (range, 3-13 years) compared with patients with metaplasia who did not progressed further than low-grade dysplasia over a mean of 5.5 years (range, 3-9 years). The intensity of staining in the index biopsy was statistically higher in progressors than in controls (P = 0.004; Fig. 3B ). Furthermore, patients with a maximum intensity (value of 3) were statistically more likely to progress to cancer than patients with a lower intensity; relative risk of progression to cancer of 3.8 (95% confidence interval, 1.5-9.9; P = 0.006).
POSTN is a TGF-β-induced secreted protein that acts as an adhesion molecule and can promote cell motility (15) . POSTN expression was significantly increased in primary esophageal fibroblasts compared with epithelial cell lines ( Fig. 3C ). Addition of cancer-associated fibroblasts (P < 0.05) or 100 ng/mL of recombinant POSTN (P < 0.01), but not normal esophagus-or dysplasia-derived fibroblasts, induced in vitro invasion of an esophageal cancer cell line FLO-1 (Fig. 3D ).
Inflammation Signature Is a General Determinant of Progression in
Gastrointestinal Tumors. To determine the significance of our findings in other cancers with a well-characterized preinvasive stage, we performed gene set enrichment analysis (GSEA). GSEA determines whether a defined set of genes correlates with a particular phenotype within microarray data. Hence, we compared our stromal datasets and a primary fibroblast gene set with gene-expression datasets from the following: whole samples from which our stromal microdissection was performed; three independent esophageal sample sets (16) (17) (18) ; and other gastrointestinal datasets from gastric (19) , colonic (20) , and pancreatic (21, 22) carcinogenic stages. There was an increasing enrichment, either up or down as expected, of the stromal and fibroblast gene sets in the progression from preinvasive stages toward invasive cancer (Fig. 4) . The set of genes identified from the upregulated stromal list was the most consistently enriched gene set across the different cancer types (Table S1 ). The pancreatic dataset by Buchholz et al., derived from microdissection epithelium, was used as a negative control. No enrichment was seen in the ductal carcinoma in situ (DCIS) to breast cancer transition. This suggests that there is a core set of stromal genes that are dysregulated in the development and progression of preinvasive disease to invasive cancer in the gastrointestinal tract.
Because of the propensity of inflammatory-related genes observed in the ontology analysis of the in-house array data (Table 1) , GSEA analysis was again applied to enriched genes involved in the inflammatory response in the nine independent datasets described above. The TGF-β, cytokine, and inflammatory pathways were consistently enriched in esophageal and colon cancer datasets compared with preinvasive disease stages (Table S2 ). TGFβ related genes were enriched in gastric cancer compared with intestinal metaplasia of the stomach (Table S2 ).
Discussion
We have identified a distinct stage-specific stromal signature in BE carcinogenesis, with predominance of inflammation-and TGFβ-related genes. Increased expression of one or more of five stromal genes was associated with a poor prognosis and had functional relevance. These inflammation-related stromal genes that distinguished between preinvasive and invasive disease in our own data were also applicable to other gastrointestinal tumors.
Only one gene expression profiling study of stroma in preinvasive disease was identified in the context of breast cancer (23) . However, their data may include a field effect bias because they selected different disease stages, which were derived from cancer endpoint. In contrast to our inflammatory signature, most differentially expressed genes in this study were linked to extracellular matrix proteins, matrix metalloproteases, and to the control of cell proliferation. In BE carcinogenesis, a single publication studied the stromal contribution by subtracting an epithelial cancer cell line signature from that obtained from a whole biopsy. The investigators identified a unique set of genes that distinguished BE and EAC samples from normal tissues (16) . Here, we performed laser capture microdissection (LCM) of the stroma in samples from discrete stages of preinvasive disease and cancer. Because of the subjective nature of the grading of dysplasia and the heterogeneity of the disease, we Table shows the ontologies conserved for each pairwise comparison for metaplasia (MET) vs. dysplasia (DYS) and dysplasia vs. EAC. All these ontologies were statistically significant in the pairwise comparisons (P < 0.05). All of the ontologies common to both pairwise comparisons are listed. The P values in the fibroblast columns indicate the ontologies also statistically different in metaplasia vs. EAC fibroblasts.
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PNAS | February 2, 2010 | vol. 107 | no. 5 | 2179 MEDICAL SCIENCES performed double-blind histopathologic diagnosis of serial sections from the same biopsies used for the expression array. Only samples homogeneous for a grade of dysplasia with a consensus diagnosis were used. The stromally derived five-gene prognostic signature comprises TMEPAI, JMY, TSP1, FAPα, and BCL6. Although not all genes are prognostic on their own, the panel is informative and underlies the collaborative action of multiple genes, culminating in the development of an invasive phenotype. We also demonstrated that increased stromal expression of TSP1 was associated with a relative risk of 3.8 (95% confidence interval, 1.5-9.9%) of developing EAC compared with controls. Together with its contribution to the prognostic signature, this makes TSP1 an interesting target to study further in the establishment and development of EAC. Other key genes dysregulated in EAC compared with preinvasive BE samples included IL-6, Cox-2, C/EBPβ, and POSTN, which are in keeping with the inflamma-tory-related pathways ascertained from the ontology and KEGG analyses. The up-regulation of inflammation-related genes and associated ontologies fits with the idea that the inflammatory microenvironment is considered to be the seventh hallmark of cancer (2) and with previous work in our laboratory and others linking inflammation and TGF-β to BE carcinogenesis (24) (25) (26) (27) . More work is required to understand the cross-talk and combined influences of the stroma and luminal components on epithelial cell behavior in BE.
The GSEA data suggest that the genes identified in the stroma and fibroblast gene sets are following similar trends of expression in the genesis of other gastrointestinal tumors. Although we identified 12 genes relevant to Barrett's carcinogenesis, it is likely that these genes represent dysregulated processes common to other gastrointestinal tumors rather than the individual oncogenes themselves being critical. Although these datasets were from whole tissues, the stromal signature did not seem diluted by the epithelial signature because only the dataset from microdissected epithelium (22) was displaying no enrichment. However, the analysis of expression profiling from whole BE tissues from the same patients presented herein did not identify the same targets as the stromal data. Therefore microdissection of the stroma was an essential first step to identify the important pathways. Interestingly, such enrichment of esophageal stromal genes was not observed in a tested breast cancer database with normal, DCIS, invasive, and metastatic ductal samples (Table S1 ). Because gastrointestinal cancers (colon, stomach, and pancreas) are well known to occur in the context of inflammation (28) (29) (30) , it is perhaps not surprising that there is a core set of stromal inflammatoryrelated genes, which are dysregulated in the progression from preinvasive disease to invasive cancer in these organs.
These data add scientific credence to the observations that antiinflammatory drugs like aspirin may have chemopreventive potential in gastrointestinal cancers (31) , and because drugs more highly targeted to specific inflammatory pathways are increasingly available, it may be possible to reverse tumor-supporting inflammation in the stroma as a new anticancer approach in the gastrointestinal tract.
Materials and Methods
A detailed description of all of the materials and methods can be found in SI Material and Methods.
Human Tissue Samples. Ethics committee approval was obtained for the study. All patients were consented. A breakdown of specimen types and sample sizes is in SI Material and Methods.
LCM, mRNA Isolation, Amplification, and Gene Expression Profiling. After microdissection of the stroma, two rounds of amplification were applied to the RNA before reverse transcription and hybridization to a 44K Agilent microarray. Transcript abundance was normalized to the Stratagene Human Universal Reference and then detrended.
Gene Expression Data Analysis. Gene expression differences between different stages of BE carcinogenesis were determined using one-way ANOVA. Only genes with more than 2-fold difference in expression between different stages were considered for further selection.
Creation of a Prognostic Panel. Junctional and esophageal tumors from 63 chemo-naïve patients were profiled, and data were normalized as described in LCM, mRNA Isolation, Amplification, and Gene Expression Profiling in SI Material and Methods. Kaplan-Meier curves were created for the 12 shortlisted targets. Each target for which dysregulated expression had a trend to confer lower survival was integrated in the prognostic panel.
Ontology Analysis. Overrepresentation of gene ontology (GO) annotation terms in gene sets was determined using GeneCoDis to group related genes on the basis of GO attributes and KEGG pathway involvement.
Gene Expression Profiling of Primary Fibroblasts. RNA extracted from the fibroblast lines was processed according to Affymetrix guidelines then hybridized to a GeneChip Human Gene 1.0 ST array. Data were analyzed using GeneSpringGX 9 software. Genes overexpressed in cancer-associated fibroblasts compared with BE-associated fibroblasts more than 2-fold were selected for gene enrichment analysis.
Nested Case-Control Study. Sixteen patients with BE who developed incident adenocarcinoma or high-grade dysplasia and two controls per patient were selected (cohort described in details in ref. 32 ). The cancer patients had at least two endoscopies before the development of high-grade dysplasia or cancer. The control cases had at least three surveillance endoscopies. The index biopsy sample was stained with TSP1.
Gene Set Enrichment Analysis. Three gene sets were generated from our microarray analyses; two from human specimens and one from primary fibroblasts. GSEA was performed using the GSEA software (http://www.broad.mit. edu/gsea/index.jsp). GSEA was performed in our in-house stromal samples and esophageal samples (from the same patients) and used to filter for genes present in both analyses at the leading edge subset. GSEA for these filtered gene-lists were run in our internal dataset as well as external datasets; esophageal (15) (16) (17) , gastric (18) and colon (19) , breast (33) , and pancreas (20, 21) .
Western Blotting, Immunostaining, Quantitative PCR, and Invasion Assays. Standards methods were used. Details can be found in SI Material and Methods.
Statistical Analysis of in Vitro Studies. Student's t test was used to identify differences between two data sets and ANOVA for multiple data sets with the Dunn's multiple comparison test as post test. P < 0.05 was required for significance. The Pearson r test was used to analyze correlation of expression of markers. Log-rank test was used to analyze the association between dysregulation of the stromal short list and survival. The Fisher exact test was used to calculate the significance of the likelihood of TSP1 intensity being higher in cases vs. controls. Stromal regions were identified by direct visual comparison with an H&E-stained section taken adjacent to the sections of interest. Epithelial regions were clearly marked by an expert gastrointestinal pathologist. The samples were collected on CapSure Macro LCM Caps (Molecular Devices). mRNA extraction was performed with the PicoPureRNA extraction kit (Molecular Devices) according to the manufacturer's instructions. mRNA was then amplified using Ambion's two-round MessageAmp II kit (Ambion, Applied Biosystems). The purification of antisense RNA after the in vitro transcription was done using Qiagen's RNeasy spin columns rather than the Ambionsupplied reagents. Five micrograms of Cy-3-and Cy-5-labeled samples with sufficient yield and quality were hybridized to custom Agilent arrays (44K Agilent microarray). Oligonucleotide probes were synthesized in situ with inkjet technology (Agilent Technologies). Each sample was hybridized twice with dye reversal. After hybridization, arrays were scanned, and fluorescence intensities for each probe were recorded. Ratios of transcript abundance (experimental to control) were obtained after normalization and correction of the array intensity data. Transcript abundance was normalized to the Stratagene Human Universal Reference RNA samples and then detrended to a detrending template to remove data bias (C-rich probes correlated with NormR/NormG ratio). The detrending template is a set of sequences chosen according to their correlation to (typically) a technical quality control variable like array probe G-C content, NormR/NormG ratio.
Gene Expression Data Analysis. Data analysis was performed with Rosetta Resolver gene expression analysis software (version 6.0; Rosetta Biosoftware), MATLAB software (version 7.0.4; Mathworks), and R. The levels of differential gene expression between different stages of BE carcinogenesis progression in the stromal samples were determined using one-way ANOVA. The P value resulting from ANOVA was compared with that expected by chance (Monte Carlo simulation). Only genes with more than 2-fold difference in expression between different stages of the progression (metaplasia, dysplasia, and EAC) were considered for further selection (see table below for filtering and selection criterion). For a gene to be selected, all of the following criteria had to be met: Any selected gene was scored according to the following criteria. Gene with a score ≥10 was selected for further analysis.
Creation of a Prognostic Panel. Junctional and esophageal tumors from 63 chemo-naïve patients collected at the Bristol Royal Infirmary (Bristol, United Kingdom) were profiled, and data were normalized as described in LCM, mRNA Isolation, Amplification, and Gene Expression Profiling above. Complete demographic and survival data are available for these patients. The median age was 67 years (range, 35-81 years), with a median length of follow-up of 20 months (range, 0.5-137 months) for all patients and 89 months (range, 66-137 months) for survivors and a male/female ratio of 1.7:1. Kaplan-Meier curves were created for each of the 12 shortlisted targets. Each target for which dysregulated expression had a trend to confer lower survival was integrated in the prognostic panel.
Ontology Analysis. To determine likely function roles of signatures, overrepresentation of GO annotation terms in gene sets was determined using GeneCoDis (1) , an online program that supports multiple testing correction. GeneCoDis was used to group related genes on the basis of GO attributes and KEGG pathway involvement. Groups of related genes common between signatures were reported as a list ordered by adjusted P value.
Isolation of Primary Stromal Fibroblasts. Tissue pieces (5-10 mm) collected from esophageal resections (patients details in table below) were maintained at 4°C in DMEM complete medium (Gibco, Invitrogen) supplemented with 20% FCS, 100 U/mL penicillin, and 100 mg/mL streptomycin and processed within 1-2 h from the time of collection. Tumor and BE tissues were derived at pathologic sites, whereas squamous tissues were collected from the resection margins as far from the tumor as possible. Samples were washed in PBS containing amphotericin B before being cut into small fragments, which were then uniformly dispersed onto an FCS-coated dish. The dish was incubated upside-down at 37°C for 3 h before addition of DMEM containing 20% FCS. The cultures were incubated at 37°C for 2 weeks. Cells were differentially trypsinized, and pure cultures of fibroblasts were generally obtained after two passages. Isolated fibroblasts were then maintained in DMEM medium supplemented with 20% FCS, 100 U/mL penicillin, 100 mg/mL streptomycin, and 2 mM L-glutamine. Fibroblasts were used in experiments up to passage 6.
Gene Expression Profiling of Primary Fibroblasts. RNA was extracted from our 13 fibroblast lines using TRIzol, and then proceeded according to the GeneChip whole transcript sense target labeling assay manual (P/N 701880 Rev. 4) using all reagents recommended by Affymetrix. Briefly, the RNA was reverse transcribed using random primers tagged with a T7 promoter sequence. The second strand was synthesized, and the dsDNA was used as a template and linear amplified by T7 RNA polymerase. The cRNA was reverse transcribed using a mixture of dNTPs and dUTP and random primers. After RNaseH digest, the ssDNA was fragmented with a combination of Uracil DNA glycosylase and apurinic/apyrimidinic endonuclease 1. The fragmented ssDNA was end-labeled by terminal deoxynucleotidyl transferase with the Affymetrix proprietary DNA labeling reagent, which is covalently linked to biotin. The fragmented and labeled ssDNA was hybridized to a GeneChip Human Gene 1.0 ST array (28, 132 genes, 764,885 probes) for 17 h and washed and scanned with the Affymetrix wash station and scanner. The generated cell-files, which contain the measured intensities for all probes, were analyzed using GeneSpring GX 9 software (Agilent Technologies).
Filtering criteria Condition
Analysis of Fibroblast Profiling Data. Hierarchical unsupervised 2D
Euclidean clustering of the stromal fibroblasts was carried out using GeneSpring GX 9. 2D supervised clustering was then carried out. Genes overexpressed in cancer-associated fibroblasts compared with BE-associated fibroblasts by more than 2-fold were selected for gene enrichment analysis.
IHC and Dual Immunofluorescent Labeling. Archival paraffin sections from an independent set of patients (see first unnumbered figure, above, for numbers) or cells grown on coverslips and fixed in paraformaldehyde were stained for a number of primary antibodies. Antibodies for IHC were visualized with the corresponding biotinylated antibodies coupled to streptavidin-peroxidase complex followed by 3,3′ diaminobenzidine. Antibodies for dual immunofluorescent labeling (DIL) were visualized with corresponding Alexa Fluor 546 or FITC-conjugated secondary antibodies. Details about antibodies and conditions used can be found in the table below. Staining was scored separately by two individuals, one of them being an expert gastrointestinal histopathologist blinded for the diagnosis.
Nested Case-Control Study. The cohort used was described in detail by Lao-Sirieix et al. (2) . Briefly, 16 patients who developed incident adenocarcinoma (9 patients) or incident high-grade dysplasia (7 patients) detected through the surveillance program were selected. Two controls were identified per patient matched, for age and length of follow-up, who did not progress. The cancer patients had at least two endoscopies before the development of high-grade dysplasia or cancer (mean follow-up of 6.5 years; range, 3-13 years). The control cases had at least three surveillance endoscopies, with no more than a single diagnosis of low-grade dysplasia (mean follow-up of 5.5 years; range, 3-9 years). The index biopsy sample (first biopsies diagnosed with metaplasia) was stained with TSP1 by IHC as discussed above. The chambers were then incubated at 37°C for 24 h, fixed for 20 min in methanol at −20°C, and then stained with hematoxylin. Cells from the upper chamber were discarded and the membrane excised and mounted onto a slide for microscopic analysis. The number of invaded cells was quantified by counting nine high-power fields. Each experiment was performed in duplicates and repeated at least three times.
Western Blotting. Proteins were separated on 8% polyacrylamide gels and transferred to PVDF membranes (Amersham Biosciences). Membranes were probed with primary antibodies (table  below) , then with the appropriate peroxidase-labeled secondary antibodies (Perbio Science), and finally the signals were detected by chemiluminescence (ECL; Amersham Biosciences).
Gene Set Enrichment Analysis. Three gene sets were generated from our microarray analyses: two from human specimens (29 genes upregulated and 26 down-regulated in the stroma of cancer samples compared with BE samples ranked solely by P value) and one from primary fibroblasts. To examine the behavior of these gene-lists, GSEA was performed using the GSEA software, publically available at http://www.broad.mit.edu/gsea/index.jsp. This computational method determines whether a defined set of genes shows differences between two sample sets, by examining the location of predefined gene sets in a ranked list of genes to identify significant changes in microarray data sets. Demographics and patient characteristics of patients whose samples were used to establish fibroblast cell lines. Cells with the same superscripted number originate from the same patient.
GSEAwas performedforthesegene-listsinternally inourin-house stromal samples and other whole-esophageal samples (full tissues containing both the epithelial and stromal compartments), and used to filter for those genes that were in both analyses present in the leading edge subset, the core of a gene set that accounts for the enrichment signal. This generated a list of 27 genes for the upregulated, 17 genes for the down-regulated stromal sets, and 12 genes for the fibroblast signature. GSEA for these filtered gene-lists were run in our internal dataset as well as external datasets; esophageal (3, 4) , gastric (5) and colon (6) , breast (7) , and pancreas (8, 9) .
To look at enrichment of the gene-lists across progression sequences, GSEA was performed on preranked lists, ranked by average expression in each stage. Statistically significant enrichment between stages was reported from pairwise GSEA between two stages.
Statistical Analysis of in Vitro Studies. The data are expressed as mean ± SD. Student's t test was used to identify differences between two data sets. In comparison of multiple data sets obtained from a single experiment, ANOVA was performed using the Kruskal-Wallis test to identify a significant change in the population. Specific differences between groups were identified after ANOVA analysis using Dunn's multiple comparison test. P < 0.05 was required for significance. The Pearson r test was used to analyze correlation of expression of markers. Log-rank test was used to analyze the association between dysregulation of the stromal short list and survival. The Fisher exact test was used to calculate the significance of the likelihood of TSP1 intensity being higher in cases vs. controls. , and an inflammatory cell marker (CD45, green) in BE carcinogenesis specimens. POSTN staining at the epithelial stromal boundary in a case of BE. Cumulative data of the localization of POSTN staining along the progression from metaplasia to EAC. Overall stroma staining refers to a weak general stromal staining. Superficial stroma refers to staining of the stroma localized within the epithelial compartment. Epithelial/stromal boundary refers to strong stromal staining in areas close to the basement membrane.
(C) TSP1 expression in the metaplasia-dysplasia-carcinoma sequence and in endothelial cells. Cumulative score for the intensity and number of thrombospondin positive cells (density) in metaplasia, dysplasia, and EAC. The intensity was scored as 1 for weak, 2 for medium, or 3 for strong staining and the density as the number of cells positive per high-power field (×400) with a score of 1 for <5 cells, 2 for 5-10 cells, 3 for 10-25 cells, and 4 for >25 cells. (D) Bright field and dark field representative images of in situ hybridization for UGT1A show expression in the epithelium and the stroma. 
